medicaid glp-1 Coverage of and Spending on GLP-1s McKee's proposed FY2027 budget drops

Dont Make This Mistake with Retatrutide Retatrutide is already making wavesand not just in clinical trials

Semaglutide and tirzeptide, in particular, have been in the news because of frequent shortages

Emerging Trends and Market Dynamics The GLP-1 market is poised for significant growth, with Novo Nordisk and Eli Lilly set to launch new injectables and oral formulations

Change meal sequences by eating protein and vegetables before carbohydrate

Noom Med costs depend on the program you select

Their use is rising rapidly, and with good reason: These medications have been shown to reduce blood sugar, improve fatty liver, GERD, sleep apnea, osteoarthritis, blood pressure, triglycerides, major adverse cardiovascular events, and even show potential benefits for conditions like alcohol use disorder (Mozaffarian et al., 2025